2023 Year in Review: CEO Yvonne Greenstreet Reflects on a Year of Substantial Growth and Progress

<!DOCTYPE html> <html lang="en" dir="ltr" prefix="content: http://purl.org/rss/1.0/modules/content/ dc: http://purl.org/dc/terms/ foaf: http://xmlns.com/foaf/0.1/ og: http://ogp.me/ns# rdfs: http://www.w3.org/2000/01/rdf-schema# schema: http://schema.org/ sioc: http://rdfs.org/sioc/ns# sioct: http://rdfs.org/sioc/types# skos: http://www.w3.org/2004/02/skos/core# xsd: http://www.w3.org/2001/XMLSchema# "> <head> <title>2023 Year in Review: CEO Yvonne Greenstreet Reflects on a Year of Substantial Growth and Progress | Alnylam® Newsroom</title> <meta name="viewport" content="width=device-width,initial-scale=1.0,maximum-scale=1.0,user-scalable=no"/>  <script> (function (w, d, s, l, i) { w[l] = w[l] || []; w[l].push({'gtm.start': new Date().getTime(), event: 'gtm.js'}); var f = d.getElementsByTagName(s)[0], j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src = 'https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f); })(window, document, 'script', 'dataLayer', 'GTM-WJ29M6J'); </script>  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.2/css/all.min.css" integrity="sha512-z3gLpd7yknf1YoNbCzqRKc4qyor8gaKU1qmn+CShxbuBusANI9QpRohGBreCFkKxLhei6S9CQXFEbbKuqLg0DA==" crossorigin="anonymous" referrerpolicy="no-referrer" /> <meta charset="utf-8" /><script type="text/javascript">(window.NREUM||(NREUM={})).init={ajax:{deny_list:["bam.nr-data.net"]}};(window.NREUM||(NREUM={})).loader_config={licenseKey:"c3ddcf012e",applicationID:"347217331"};;/*! For license information please see nr-loader-rum-1.274.0.min.js.LICENSE.txt */ (()=>{var e,t,r={8122:(e,t,r)=>{"use strict";r.d(t,{a:()=>i});var n=r(944);function i(e,t){try{if(!e||"object"!=typeof e)return(0,n.R)(3);if(!t||"object"!=typeof t)return(0,n.R)(4);const r=Object.create(Object.getPrototypeOf(t),Object.getOwnPropertyDescriptors(t)),o=0===Object.keys(r).length?e:r;for(let a in o)if(void 0!==e[a])try{if(null===e[a]){r[a]=null;continue}Array.isArray(e[a])&&Array.isArray(t[a])?r[a]=Array.from(new Set([...e[a],...t[a]])):"object"==typeof e[a]&&"object"==typeof t[a]?r[a]=i(e[a],t[a]):r[a]=e[a]}catch(e){(0,n.R)(1,e)}return r}catch(e){(0,n.R)(2,e)}}},2555:(e,t,r)=>{"use strict";r.d(t,{Vp:()=>c,fn:()=>s,x1:()=>u});var n=r(384),i=r(8122);const o={beacon:n.NT.beacon,errorBeacon:n.NT.errorBeacon,licenseKey:void 0,applicationID:void 0,sa:void 0,queueTime:void 0,applicationTime:void 0,ttGuid:void 0,user:void 0,account:void 0,product:void 0,extra:void 0,jsAttributes:{},userAttributes:void 0,atts:void 0,transactionName:void 0,tNamePlain:void 0},a={};function s(e){try{const t=c(e);return!!t.licenseKey&&!!t.errorBeacon&&!!t.applicationID}catch(e){return!1}}function c(e){if(!e)throw new Error("All info objects require an agent identifier!");if(!a[e])throw new Error("Info for ".concat(e," was never set"));return a[e]}function u(e,t){if(!e)throw new Error("All info objects require an agent identifier!");a[e]=(0,i.a)(t,o);const r=(0,n.nY)(e);r&&(r.info=a[e])}},9417:(e,t,r)=>{"use strict";r.d(t,{D0:()=>g,gD:()=>h,xN:()=>p});var n=r(993);const i=e=>{if(!e||"string"!=typeof e)return!1;try{document.createDocumentFragment().querySelector(e)}catch{return!1}return!0};var o=r(2614),a=r(944),s=r(384),c=r(8122);const u="[data-nr-mask]",d=()=>{const e={mask_selector:"*",block_selector:"[data-nr-block]",mask_input_options:{color:!1,date:!1,"datetime-local":!1,email:!1,month:!1,number:!1,range:!1,search:!1,tel:!1,text:!1,time:!1,url:!1,week:!1,textarea:!1,select:!1,password:!0}};return{ajax:{deny_list:void 0,block_internal:!0,enabled:!0,harvestTimeSeconds:10,autoStart:!0},distributed_tracing:{enabled:void 0,exclude_newrelic_header:void 0,cors_use_newrelic_header:void 0,cors_use_tracecontext_headers:void 0,allowed_origins:void 0},feature_flags:[],generic_events:{enabled:!0,harvestTimeSeconds:30,autoStart:!0},harvest:{tooManyRequestsDelay:60},jserrors:{enabled:!0,harvestTimeSeconds:10,autoStart:!0},logging:{enabled:!0,harvestTimeSeconds:10,autoStart:!0,level:n.p_.INFO},metrics:{enabled:!0,autoStart:!0},obfuscate:void 0,page_action:{enabled:!0},page_view_event:{enabled:!0,autoStart:!0},page_view_timing:{enabled:!0,harvestTimeSeconds:30,autoStart:!0},performance:{capture_marks:!1,capture_measures:!1},privacy:{cookies_enabled:!0},proxy:{assets:void 0,beacon:void 0},session:{expiresMs:o.wk,inactiveMs:o.BB},session_replay:{autoStart:!0,enabled:!1,harvestTimeSeconds:60,preload:!1,sampling_rate:10,error_sampling_rate:100,collect_fonts:!1,inline_images:!1,fix_stylesheets:!0,mask_all_inputs:!0,get mask_text_selector(){return e.mask_selector},set mask_text_selector(t){i(t)?e.mask_selector="".concat(t,",").concat(u):""===t||null===t?e.mask_selector=u:(0,a.R)(5,t)},get block_class(){return"nr-block"},get ignore_class(){return"nr-ignore"},get mask_text_class(){return"nr-mask"},get block_selector(){return e.block_selector},set block_selector(t){i(t)?e.block_selector+=",".concat(t):""!==t&&(0,a.R)(6,t)},get mask_input_options(){return e.mask_input_options},set mask_input_options(t){t&&"object"==typeof t?e.mask_input_options={...t,password:!0}:(0,a.R)(7,t)}},session_trace:{enabled:!0,harvestTimeSeconds:10,autoStart:!0},soft_navigations:{enabled:!0,harvestTimeSeconds:10,autoStart:!0},spa:{enabled:!0,harvestTimeSeconds:10,autoStart:!0},ssl:void 0,user_actions:{enabled:!0}}},l={},f="All configuration objects require an agent identifier!";function g(e){if(!e)throw new Error(f);if(!l[e])throw new Error("Configuration for ".concat(e," was never set"));return l[e]}function p(e,t){if(!e)throw new Error(f);l[e]=(0,c.a)(t,d());const r=(0,s.nY)(e);r&&(r.init=l[e])}function h(e,t){if(!e)throw new Error(f);var r=g(e);if(r){for(var n=t.split("."),i=0;i<n.length-1;i++)if("object"!=typeof(r=r[n[i]]))return;r=r[n[n.length-1]]}return r}},3371:(e,t,r)=>{"use strict";r.d(t,{V:()=>f,f:()=>l});var n=r(8122),i=r(384),o=r(6154),a=r(9324);let s=0;const c={buildEnv:a.F3,distMethod:a.Xs,version:a.xv,originTime:o.WN},u={customTransaction:void 0,disabled:!1,isolatedBacklog:!1,loaderType:void 0,maxBytes:3e4,onerror:void 0,ptid:void 0,releaseIds:{},appMetadata:{},session:void 0,denyList:void 0,timeKeeper:void 0,obfuscator:void 0},d={};function l(e){if(!e)throw new Error("All runtime objects require an agent identifier!");if(!d[e])throw new Error("Runtime for ".concat(e," was never set"));return d[e]}function f(e,t){if(!e)throw new Error("All runtime objects require an agent identifier!");d[e]={...(0,n.a)(t,u),...c},Object.hasOwnProperty.call(d[e],"harvestCount")||Object.defineProperty(d[e],"harvestCount",{get:()=>++s});const r=(0,i.nY)(e);r&&(r.runtime=d[e])}},9324:(e,t,r)=>{"use strict";r.d(t,{F3:()=>i,Xs:()=>o,xv:()=>n});const n="1.274.0",i="PROD",o="CDN"},6154:(e,t,r)=>{"use strict";r.d(t,{OF:()=>c,RI:()=>i,WN:()=>d,bv:()=>o,gm:()=>a,mw:()=>s,sb:()=>u});var n=r(1863);const i="undefined"!=typeof window&&!!window.document,o="undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self.navigator instanceof WorkerNavigator||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis.navigator instanceof WorkerNavigator),a=i?window:"undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis),s=Boolean("hidden"===a?.document?.visibilityState),c=/iPad|iPhone|iPod/.test(a.navigator?.userAgent),u=c&&"undefined"==typeof SharedWorker,d=((()=>{const e=a.navigator?.userAgent?.match(/Firefox[/\s](\d+\.\d+)/);Array.isArray(e)&&e.length>=2&&e[1]})(),Date.now()-(0,n.t)())},1687:(e,t,r)=>{"use strict";r.d(t,{Ak:()=>c,Ze:()=>l,x3:()=>u});var n=r(7836),i=r(3606),o=r(860),a=r(2646);const s={};function c(e,t){const r={staged:!1,priority:o.P3[t]||0};d(e),s[e].get(t)||s[e].set(t,r)}function u(e,t){e&&s[e]&&(s[e].get(t)&&s[e].delete(t),g(e,t,!1),s[e].size&&f(e))}function d(e){if(!e)throw new Error("agentIdentifier required");s[e]||(s[e]=new Map)}function l(e="",t="feature",r=!1){if(d(e),!e||!s[e].get(t)||r)return g(e,t);s[e].get(t).staged=!0,f(e)}function f(e){const t=Array.from(s[e]);t.every((([e,t])=>t.staged))&&(t.sort(((e,t)=>e[1].priority-t[1].priority)),t.forEach((([t])=>{s[e].delete(t),g(e,t)})))}function g(e,t,r=!0){const o=e?n.ee.get(e):n.ee,s=i.i.handlers;if(!o.aborted&&o.backlog&&s){if(r){const e=o.backlog[t],r=s[t];if(r){for(let t=0;e&&t<e.length;++t)p(e[t],r);Object.entries(r).forEach((([e,t])=>{Object.values(t||{}).forEach((t=>{t[0]?.on&&t[0]?.context()instanceof a.y&&t[0].on(e,t[1])}))}))}}o.isolatedBacklog||delete s[t],o.backlog[t]=null,o.emit("drain-"+t,[])}}function p(e,t){var r=e[1];Object.values(t[r]||{}).forEach((t=>{var r=e[0];if(t[0]===r){var n=t[1],i=e[3],o=e[2];n.apply(i,o)}}))}},7836:(e,t,r)=>{"use strict";r.d(t,{P:()=>c,ee:()=>u});var n=r(384),i=r(8990),o=r(3371),a=r(2646),s=r(5607);const c="nr@context:".concat(s.W),u=function e(t,r){var n={},s={},d={},l=!1;try{l=16===r.length&&(0,o.f)(r).isolatedBacklog}catch(e){}var f={on:p,addEventListener:p,removeEventListener:function(e,t){var r=n[e];if(!r)return;for(var i=0;i<r.length;i++)r[i]===t&&r.splice(i,1)},emit:function(e,r,n,i,o){!1!==o&&(o=!0);if(u.aborted&&!i)return;t&&o&&t.emit(e,r,n);for(var a=g(n),c=h(e),d=c.length,l=0;l<d;l++)c[l].apply(a,r);var p=m()[s[e]];p&&p.push([f,e,r,a]);return a},get:v,listeners:h,context:g,buffer:function(e,t){const r=m();if(t=t||"feature",f.aborted)return;Object.entries(e||{}).forEach((([e,n])=>{s[n]=t,t in r||(r[t]=[])}))},abort:function(){f._aborted=!0,Object.keys(f.backlog).forEach((e=>{delete f.backlog[e]}))},isBuffering:function(e){return!!m()[s[e]]},debugId:r,backlog:l?{}:t&&"object"==typeof t.backlog?t.backlog:{},isolatedBacklog:l};return Object.defineProperty(f,"aborted",{get:()=>{let e=f._aborted||!1;return e||(t&&(e=t.aborted),e)}}),f;function g(e){return e&&e instanceof a.y?e:e?(0,i.I)(e,c,(()=>new a.y(c))):new a.y(c)}function p(e,t){n[e]=h(e).concat(t)}function h(e){return n[e]||[]}function v(t){return d[t]=d[t]||e(f,t)}function m(){return f.backlog}}(void 0,"globalEE"),d=(0,n.Zm)();d.ee||(d.ee=u)},2646:(e,t,r)=>{"use strict";r.d(t,{y:()=>n});class n{constructor(e){this.contextId=e}}},9908:(e,t,r)=>{"use strict";r.d(t,{d:()=>n,p:()=>i});var n=r(7836).ee.get("handle");function i(e,t,r,i,o){o?(o.buffer([e],i),o.emit(e,t,r)):(n.buffer([e],i),n.emit(e,t,r))}},3606:(e,t,r)=>{"use strict";r.d(t,{i:()=>o});var n=r(9908);o.on=a;var i=o.handlers={};function o(e,t,r,o){a(o||n.d,i,e,t,r)}function a(e,t,r,i,o){o||(o="feature"),e||(e=n.d);var a=t[o]=t[o]||{};(a[r]=a[r]||[]).push([e,i])}},3878:(e,t,r)=>{"use strict";function n(e,t){return{capture:e,passive:!1,signal:t}}function i(e,t,r=!1,i){window.addEventListener(e,t,n(r,i))}function o(e,t,r=!1,i){document.addEventListener(e,t,n(r,i))}r.d(t,{DD:()=>o,jT:()=>n,sp:()=>i})},5607:(e,t,r)=>{"use strict";r.d(t,{W:()=>n});const n=(0,r(9566).bz)()},9566:(e,t,r)=>{"use strict";r.d(t,{LA:()=>s,bz:()=>a});var n=r(6154);const i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx";function o(e,t){return e?15&e[t]:16*Math.random()|0}function a(){const e=n.gm?.crypto||n.gm?.msCrypto;let t,r=0;return e&&e.getRandomValues&&(t=e.getRandomValues(new Uint8Array(30))),i.split("").map((e=>"x"===e?o(t,r++).toString(16):"y"===e?(3&o()|8).toString(16):e)).join("")}function s(e){const t=n.gm?.crypto||n.gm?.msCrypto;let r,i=0;t&&t.getRandomValues&&(r=t.getRandomValues(new Uint8Array(e)));const a=[];for(var s=0;s<e;s++)a.push(o(r,i++).toString(16));return a.join("")}},2614:(e,t,r)=>{"use strict";r.d(t,{BB:()=>a,H3:()=>n,g:()=>u,iL:()=>c,tS:()=>s,uh:()=>i,wk:()=>o});const n="NRBA",i="SESSION",o=144e5,a=18e5,s={STARTED:"session-started",PAUSE:"session-pause",RESET:"session-reset",RESUME:"session-resume",UPDATE:"session-update"},c={SAME_TAB:"same-tab",CROSS_TAB:"cross-tab"},u={OFF:0,FULL:1,ERROR:2}},1863:(e,t,r)=>{"use strict";function n(){return Math.floor(performance.now())}r.d(t,{t:()=>n})},944:(e,t,r)=>{"use strict";function n(e,t){"function"==typeof console.debug&&console.debug("New Relic Warning: https://github.com/newrelic/newrelic-browser-agent/blob/main/docs/warning-codes.md#".concat(e),t)}r.d(t,{R:()=>n})},5284:(e,t,r)=>{"use strict";r.d(t,{t:()=>c,B:()=>s});var n=r(7836),i=r(6154);const o="newrelic";const a=new Set,s={};function c(e,t){const r=n.ee.get(t);s[t]??={},e&&"object"==typeof e&&(a.has(t)||(r.emit("rumresp",[e]),s[t]=e,a.add(t),function(e={}){try{i.gm.dispatchEvent(new CustomEvent(o,{detail:e}))}catch(e){}}({loaded:!0})))}},8990:(e,t,r)=>{"use strict";r.d(t,{I:()=>i});var n=Object.prototype.hasOwnProperty;function i(e,t,r){if(n.call(e,t))return e[t];var i=r();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,t,{value:i,writable:!0,enumerable:!1}),i}catch(e){}return e[t]=i,i}},6389:(e,t,r)=>{"use strict";function n(e,t=500,r={}){const n=r?.leading||!1;let i;return(...r)=>{n&&void 0===i&&(e.apply(this,r),i=setTimeout((()=>{i=clearTimeout(i)}),t)),n||(clearTimeout(i),i=setTimeout((()=>{e.apply(this,r)}),t))}}function i(e){let t=!1;return(...r)=>{t||(t=!0,e.apply(this,r))}}r.d(t,{J:()=>i,s:()=>n})},5289:(e,t,r)=>{"use strict";r.d(t,{GG:()=>o,sB:()=>a});var n=r(3878);function i(){return"undefined"==typeof document||"complete"===document.readyState}function o(e,t){if(i())return e();(0,n.sp)("load",e,t)}function a(e){if(i())return e();(0,n.DD)("DOMContentLoaded",e)}},384:(e,t,r)=>{"use strict";r.d(t,{NT:()=>o,US:()=>d,Zm:()=>a,bQ:()=>c,dV:()=>s,nY:()=>u,pV:()=>l});var n=r(6154),i=r(1863);const o={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net"};function a(){return n.gm.NREUM||(n.gm.NREUM={}),void 0===n.gm.newrelic&&(n.gm.newrelic=n.gm.NREUM),n.gm.NREUM}function s(){let e=a();return e.o||(e.o={ST:n.gm.setTimeout,SI:n.gm.setImmediate,CT:n.gm.clearTimeout,XHR:n.gm.XMLHttpRequest,REQ:n.gm.Request,EV:n.gm.Event,PR:n.gm.Promise,MO:n.gm.MutationObserver,FETCH:n.gm.fetch,WS:n.gm.WebSocket}),e}function c(e,t){let r=a();r.initializedAgents??={},t.initializedAt={ms:(0,i.t)(),date:new Date},r.initializedAgents[e]=t}function u(e){let t=a();return t.initializedAgents?.[e]}function d(e,t){a()[e]=t}function l(){return function(){let e=a();const t=e.info||{};e.info={beacon:o.beacon,errorBeacon:o.errorBeacon,...t}}(),function(){let e=a();const t=e.init||{};e.init={...t}}(),s(),function(){let e=a();const t=e.loader_config||{};e.loader_config={...t}}(),a()}},2843:(e,t,r)=>{"use strict";r.d(t,{u:()=>i});var n=r(3878);function i(e,t=!1,r,i){(0,n.DD)("visibilitychange",(function(){if(t)return void("hidden"===document.visibilityState&&e());e(document.visibilityState)}),r,i)}},3434:(e,t,r)=>{"use strict";r.d(t,{YM:()=>c});var n=r(7836),i=r(5607);const o="nr@original:".concat(i.W);var a=Object.prototype.hasOwnProperty,s=!1;function c(e,t){return e||(e=n.ee),r.inPlace=function(e,t,n,i,o){n||(n="");const a="-"===n.charAt(0);for(let s=0;s<t.length;s++){const c=t[s],u=e[c];d(u)||(e[c]=r(u,a?c+n:n,i,c,o))}},r.flag=o,r;function r(t,r,n,s,c){return d(t)?t:(r||(r=""),nrWrapper[o]=t,function(e,t,r){if(Object.defineProperty&&Object.keys)try{return Object.keys(e).forEach((function(r){Object.defineProperty(t,r,{get:function(){return e[r]},set:function(t){return e[r]=t,t}})})),t}catch(e){u([e],r)}for(var n in e)a.call(e,n)&&(t[n]=e[n])}(t,nrWrapper,e),nrWrapper);function nrWrapper(){var o,a,d,l;try{a=this,o=[...arguments],d="function"==typeof n?n(o,a):n||{}}catch(t){u([t,"",[o,a,s],d],e)}i(r+"start",[o,a,s],d,c);try{return l=t.apply(a,o)}catch(e){throw i(r+"err",[o,a,e],d,c),e}finally{i(r+"end",[o,a,l],d,c)}}}function i(r,n,i,o){if(!s||t){var a=s;s=!0;try{e.emit(r,n,i,t,o)}catch(t){u([t,r,n,i],e)}s=a}}}function u(e,t){t||(t=n.ee);try{t.emit("internal-error",e)}catch(e){}}function d(e){return!(e&&"function"==typeof e&&e.apply&&!e[o])}},993:(e,t,r)=>{"use strict";r.d(t,{ET:()=>o,p_:()=>i});var n=r(860);const i={ERROR:"ERROR",WARN:"WARN",INFO:"INFO",DEBUG:"DEBUG",TRACE:"TRACE"},o="log";n.K7.logging},3969:(e,t,r)=>{"use strict";r.d(t,{TZ:()=>n,XG:()=>s,rs:()=>i,xV:()=>a,z_:()=>o});const n=r(860).K7.metrics,i="sm",o="cm",a="storeSupportabilityMetrics",s="storeEventMetrics"},6630:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.pageViewEvent},782:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.pageViewTiming},6344:(e,t,r)=>{"use strict";r.d(t,{G4:()=>i});var n=r(2614);r(860).K7.sessionReplay;const i={RECORD:"recordReplay",PAUSE:"pauseReplay",REPLAY_RUNNING:"replayRunning",ERROR_DURING_REPLAY:"errorDuringReplay"};n.g.ERROR,n.g.FULL,n.g.OFF},4234:(e,t,r)=>{"use strict";r.d(t,{W:()=>o});var n=r(7836),i=r(1687);class o{constructor(e,t){this.agentIdentifier=e,this.ee=n.ee.get(e),this.featureName=t,this.blocked=!1}deregisterDrain(){(0,i.x3)(this.agentIdentifier,this.featureName)}}},7603:(e,t,r)=>{"use strict";r.d(t,{j:()=>P});var n=r(860),i=r(2555),o=r(3371),a=r(9908),s=r(7836),c=r(1687),u=r(5289),d=r(6154),l=r(944),f=r(3969),g=r(384),p=r(6344);const h=["setErrorHandler","finished","addToTrace","addRelease","addPageAction","setCurrentRouteName","setPageViewName","setCustomAttribute","interaction","noticeError","setUserId","setApplicationVersion","start",p.G4.RECORD,p.G4.PAUSE,"log","wrapLogger"],v=["setErrorHandler","finished","addToTrace","addRelease"];var m=r(1863),b=r(2614),y=r(993);var w=r(2646),A=r(3434);function R(e,t,r,n){if("object"!=typeof t||!t||"string"!=typeof r||!r||"function"!=typeof t[r])return(0,l.R)(29);const i=function(e){return(e||s.ee).get("logger")}(e),o=(0,A.YM)(i),a=new w.y(s.P);return a.level=n.level,a.customAttributes=n.customAttributes,o.inPlace(t,[r],"wrap-logger-",a),i}function E(){const e=(0,g.pV)();h.forEach((t=>{e[t]=(...r)=>function(t,...r){let n=[];return Object.values(e.initializedAgents).forEach((e=>{e&&e.api?e.exposed&&e.api[t]&&n.push(e.api[t](...r)):(0,l.R)(38,t)})),n.length>1?n:n[0]}(t,...r)}))}const x={};function _(e,t,g=!1){t||(0,c.Ak)(e,"api");const h={};var w=s.ee.get(e),A=w.get("tracer");x[e]=b.g.OFF,w.on(p.G4.REPLAY_RUNNING,(t=>{x[e]=t}));var E="api-",_=E+"ixn-";function N(t,r,n,o){const a=(0,i.Vp)(e);return null===r?delete a.jsAttributes[t]:(0,i.x1)(e,{...a,jsAttributes:{...a.jsAttributes,[t]:r}}),j(E,n,!0,o||null===r?"session":void 0)(t,r)}function T(){}h.log=function(e,{customAttributes:t={},level:r=y.p_.INFO}={}){(0,a.p)(f.xV,["API/log/called"],void 0,n.K7.metrics,w),function(e,t,r={},i=y.p_.INFO){(0,a.p)(f.xV,["API/logging/".concat(i.toLowerCase(),"/called")],void 0,n.K7.metrics,e),(0,a.p)(y.ET,[(0,m.t)(),t,r,i],void 0,n.K7.logging,e)}(w,e,t,r)},h.wrapLogger=(e,t,{customAttributes:r={},level:i=y.p_.INFO}={})=>{(0,a.p)(f.xV,["API/wrapLogger/called"],void 0,n.K7.metrics,w),R(w,e,t,{customAttributes:r,level:i})},v.forEach((e=>{h[e]=j(E,e,!0,"api")})),h.addPageAction=j(E,"addPageAction",!0,n.K7.genericEvents),h.setPageViewName=function(t,r){if("string"==typeof t)return"/"!==t.charAt(0)&&(t="/"+t),(0,o.f)(e).customTransaction=(r||"http://custom.transaction")+t,j(E,"setPageViewName",!0)()},h.setCustomAttribute=function(e,t,r=!1){if("string"==typeof e){if(["string","number","boolean"].includes(typeof t)||null===t)return N(e,t,"setCustomAttribute",r);(0,l.R)(40,typeof t)}else(0,l.R)(39,typeof e)},h.setUserId=function(e){if("string"==typeof e||null===e)return N("enduser.id",e,"setUserId",!0);(0,l.R)(41,typeof e)},h.setApplicationVersion=function(e){if("string"==typeof e||null===e)return N("application.version",e,"setApplicationVersion",!1);(0,l.R)(42,typeof e)},h.start=()=>{try{(0,a.p)(f.xV,["API/start/called"],void 0,n.K7.metrics,w),w.emit("manual-start-all")}catch(e){(0,l.R)(23,e)}},h[p.G4.RECORD]=function(){(0,a.p)(f.xV,["API/recordReplay/called"],void 0,n.K7.metrics,w),(0,a.p)(p.G4.RECORD,[],void 0,n.K7.sessionReplay,w)},h[p.G4.PAUSE]=function(){(0,a.p)(f.xV,["API/pauseReplay/called"],void 0,n.K7.metrics,w),(0,a.p)(p.G4.PAUSE,[],void 0,n.K7.sessionReplay,w)},h.interaction=function(e){return(new T).get("object"==typeof e?e:{})};const S=T.prototype={createTracer:function(e,t){var r={},i=this,o="function"==typeof t;return(0,a.p)(f.xV,["API/createTracer/called"],void 0,n.K7.metrics,w),g||(0,a.p)(_+"tracer",[(0,m.t)(),e,r],i,n.K7.spa,w),function(){if(A.emit((o?"":"no-")+"fn-start",[(0,m.t)(),i,o],r),o)try{return t.apply(this,arguments)}catch(e){const t="string"==typeof e?new Error(e):e;throw A.emit("fn-err",[arguments,this,t],r),t}finally{A.emit("fn-end",[(0,m.t)()],r)}}}};function j(e,t,r,i){return function(){return(0,a.p)(f.xV,["API/"+t+"/called"],void 0,n.K7.metrics,w),i&&(0,a.p)(e+t,[(0,m.t)(),...arguments],r?null:this,i,w),r?void 0:this}}function k(){r.e(296).then(r.bind(r,8778)).then((({setAPI:t})=>{t(e),(0,c.Ze)(e,"api")})).catch((e=>{(0,l.R)(27,e),w.abort()}))}return["actionText","setName","setAttribute","save","ignore","onEnd","getContext","end","get"].forEach((e=>{S[e]=j(_,e,void 0,g?n.K7.softNav:n.K7.spa)})),h.setCurrentRouteName=g?j(_,"routeName",void 0,n.K7.softNav):j(E,"routeName",!0,n.K7.spa),h.noticeError=function(t,r){"string"==typeof t&&(t=new Error(t)),(0,a.p)(f.xV,["API/noticeError/called"],void 0,n.K7.metrics,w),(0,a.p)("err",[t,(0,m.t)(),!1,r,!!x[e]],void 0,n.K7.jserrors,w)},d.RI?(0,u.GG)((()=>k()),!0):k(),h}var N=r(9417),T=r(8122);const S={accountID:void 0,trustKey:void 0,agentID:void 0,licenseKey:void 0,applicationID:void 0,xpid:void 0},j={};var k=r(5284);const I=e=>{const t=e.startsWith("http");e+="/",r.p=t?e:"https://"+e};let O=!1;function P(e,t={},r,n){let{init:a,info:c,loader_config:u,runtime:l={},exposed:f=!0}=t;l.loaderType=r;const p=(0,g.pV)();c||(a=p.init,c=p.info,u=p.loader_config),(0,N.xN)(e.agentIdentifier,a||{}),function(e,t){if(!e)throw new Error("All loader-config objects require an agent identifier!");j[e]=(0,T.a)(t,S);const r=(0,g.nY)(e);r&&(r.loader_config=j[e])}(e.agentIdentifier,u||{}),c.jsAttributes??={},d.bv&&(c.jsAttributes.isWorker=!0),(0,i.x1)(e.agentIdentifier,c);const h=(0,N.D0)(e.agentIdentifier),v=[c.beacon,c.errorBeacon];O||(h.proxy.assets&&(I(h.proxy.assets),v.push(h.proxy.assets)),h.proxy.beacon&&v.push(h.proxy.beacon),E(),(0,g.US)("activatedFeatures",k.B),e.runSoftNavOverSpa&&=!0===h.soft_navigations.enabled&&h.feature_flags.includes("soft_nav")),l.denyList=[...h.ajax.deny_list||[],...h.ajax.block_internal?v:[]],l.ptid=e.agentIdentifier,(0,o.V)(e.agentIdentifier,l),e.ee=s.ee.get(e.agentIdentifier),void 0===e.api&&(e.api=_(e.agentIdentifier,n,e.runSoftNavOverSpa)),void 0===e.exposed&&(e.exposed=f),O=!0}},8374:(e,t,r)=>{r.nc=(()=>{try{return document?.currentScript?.nonce}catch(e){}return""})()},860:(e,t,r)=>{"use strict";r.d(t,{$J:()=>o,K7:()=>n,P3:()=>i});const n={ajax:"ajax",genericEvents:"generic_events",jserrors:"jserrors",logging:"logging",metrics:"metrics",pageAction:"page_action",pageViewEvent:"page_view_event",pageViewTiming:"page_view_timing",sessionReplay:"session_replay",sessionTrace:"session_trace",softNav:"soft_navigations",spa:"spa"},i={[n.pageViewEvent]:1,[n.pageViewTiming]:2,[n.metrics]:3,[n.jserrors]:4,[n.spa]:5,[n.ajax]:6,[n.sessionTrace]:7,[n.softNav]:8,[n.sessionReplay]:9,[n.logging]:10,[n.genericEvents]:11},o={[n.pageViewTiming]:"events",[n.ajax]:"events",[n.spa]:"events",[n.softNav]:"events",[n.metrics]:"jserrors",[n.jserrors]:"jserrors",[n.sessionTrace]:"browser/blobs",[n.sessionReplay]:"browser/blobs",[n.logging]:"browser/logs",[n.genericEvents]:"ins"}}},n={};function i(e){var t=n[e];if(void 0!==t)return t.exports;var o=n[e]={exports:{}};return r[e](o,o.exports,i),o.exports}i.m=r,i.d=(e,t)=>{for(var r in t)i.o(t,r)&&!i.o(e,r)&&Object.defineProperty(e,r,{enumerable:!0,get:t[r]})},i.f={},i.e=e=>Promise.all(Object.keys(i.f).reduce(((t,r)=>(i.f[r](e,t),t)),[])),i.u=e=>"nr-rum-1.274.0.min.js",i.o=(e,t)=>Object.prototype.hasOwnProperty.call(e,t),e={},t="NRBA-1.274.0.PROD:",i.l=(r,n,o,a)=>{if(e[r])e[r].push(n);else{var s,c;if(void 0!==o)for(var u=document.getElementsByTagName("script"),d=0;d<u.length;d++){var l=u[d];if(l.getAttribute("src")==r||l.getAttribute("data-webpack")==t+o){s=l;break}}if(!s){c=!0;var f={296:"sha512-gkYkZDAwQ9PwaDXs2YM+rNIdRej1Ac1mupWobRJ8eahQcXz6/sunGZCKklrzi5kWxhOGRZr2tn0rEKuLTXzfAA=="};(s=document.createElement("script")).charset="utf-8",s.timeout=120,i.nc&&s.setAttribute("nonce",i.nc),s.setAttribute("data-webpack",t+o),s.src=r,0!==s.src.indexOf(window.location.origin+"/")&&(s.crossOrigin="anonymous"),f[a]&&(s.integrity=f[a])}e[r]=[n];var g=(t,n)=>{s.onerror=s.onload=null,clearTimeout(p);var i=e[r];if(delete e[r],s.parentNode&&s.parentNode.removeChild(s),i&&i.forEach((e=>e(n))),t)return t(n)},p=setTimeout(g.bind(null,void 0,{type:"timeout",target:s}),12e4);s.onerror=g.bind(null,s.onerror),s.onload=g.bind(null,s.onload),c&&document.head.appendChild(s)}},i.r=e=>{"undefined"!=typeof Symbol&&Symbol.toStringTag&&Object.defineProperty(e,Symbol.toStringTag,{value:"Module"}),Object.defineProperty(e,"__esModule",{value:!0})},i.p="https://js-agent.newrelic.com/",(()=>{var e={840:0,374:0};i.f.j=(t,r)=>{var n=i.o(e,t)?e[t]:void 0;if(0!==n)if(n)r.push(n[2]);else{var o=new Promise(((r,i)=>n=e[t]=[r,i]));r.push(n[2]=o);var a=i.p+i.u(t),s=new Error;i.l(a,(r=>{if(i.o(e,t)&&(0!==(n=e[t])&&(e[t]=void 0),n)){var o=r&&("load"===r.type?"missing":r.type),a=r&&r.target&&r.target.src;s.message="Loading chunk "+t+" failed.\n("+o+": "+a+")",s.name="ChunkLoadError",s.type=o,s.request=a,n[1](s)}}),"chunk-"+t,t)}};var t=(t,r)=>{var n,o,[a,s,c]=r,u=0;if(a.some((t=>0!==e[t]))){for(n in s)i.o(s,n)&&(i.m[n]=s[n]);if(c)c(i)}for(t&&t(r);u<a.length;u++)o=a[u],i.o(e,o)&&e[o]&&e[o][0](),e[o]=0},r=self["webpackChunk:NRBA-1.274.0.PROD"]=self["webpackChunk:NRBA-1.274.0.PROD"]||[];r.forEach(t.bind(null,0)),r.push=t.bind(null,r.push.bind(r))})(),(()=>{"use strict";i(8374);var e=i(944),t=i(6344),r=i(9566);class n{agentIdentifier;constructor(e=(0,r.LA)(16)){this.agentIdentifier=e}#e(t,...r){if("function"==typeof this.api?.[t])return this.api[t](...r);(0,e.R)(35,t)}addPageAction(e,t){return this.#e("addPageAction",e,t)}setPageViewName(e,t){return this.#e("setPageViewName",e,t)}setCustomAttribute(e,t,r){return this.#e("setCustomAttribute",e,t,r)}noticeError(e,t){return this.#e("noticeError",e,t)}setUserId(e){return this.#e("setUserId",e)}setApplicationVersion(e){return this.#e("setApplicationVersion",e)}setErrorHandler(e){return this.#e("setErrorHandler",e)}addRelease(e,t){return this.#e("addRelease",e,t)}log(e,t){return this.#e("log",e,t)}}class o extends n{#e(t,...r){if("function"==typeof this.api?.[t])return this.api[t](...r);(0,e.R)(35,t)}start(){return this.#e("start")}finished(e){return this.#e("finished",e)}recordReplay(){return this.#e(t.G4.RECORD)}pauseReplay(){return this.#e(t.G4.PAUSE)}addToTrace(e){return this.#e("addToTrace",e)}setCurrentRouteName(e){return this.#e("setCurrentRouteName",e)}interaction(){return this.#e("interaction")}wrapLogger(e,t,r){return this.#e("wrapLogger",e,t,r)}}var a=i(860),s=i(9417);const c=Object.values(a.K7);function u(e){const t={};return c.forEach((r=>{t[r]=function(e,t){return!0===(0,s.gD)(t,"".concat(e,".enabled"))}(r,e)})),t}var d=i(7603);var l=i(1687),f=i(4234),g=i(5289),p=i(6154),h=i(384);const v=e=>p.RI&&!0===(0,s.gD)(e,"privacy.cookies_enabled");function m(e){return!!(0,h.dV)().o.MO&&v(e)&&!0===(0,s.gD)(e,"session_trace.enabled")}var b=i(6389);class y extends f.W{constructor(e,t,r=!0){super(e.agentIdentifier,t),this.auto=r,this.abortHandler=void 0,this.featAggregate=void 0,this.onAggregateImported=void 0,!1===e.init[this.featureName].autoStart&&(this.auto=!1),this.auto?(0,l.Ak)(e.agentIdentifier,t):this.ee.on("manual-start-all",(0,b.J)((()=>{(0,l.Ak)(e.agentIdentifier,this.featureName),this.auto=!0,this.importAggregator(e)})))}importAggregator(t,r={}){if(this.featAggregate||!this.auto)return;let n;this.onAggregateImported=new Promise((e=>{n=e}));const o=async()=>{let o;try{if(v(this.agentIdentifier)){const{setupAgentSession:e}=await i.e(296).then(i.bind(i,3861));o=e(t)}}catch(t){(0,e.R)(20,t),this.ee.emit("internal-error",[t]),this.featureName===a.K7.sessionReplay&&this.abortHandler?.()}try{if(t.sharedAggregator)await t.sharedAggregator;else{t.sharedAggregator=i.e(296).then(i.bind(i,9337));const{EventAggregator:e}=await t.sharedAggregator;t.sharedAggregator=new e}if(!this.#t(this.featureName,o))return(0,l.Ze)(this.agentIdentifier,this.featureName),void n(!1);const{lazyFeatureLoader:e}=await i.e(296).then(i.bind(i,6103)),{Aggregate:a}=await e(this.featureName,"aggregate");this.featAggregate=new a(t,r),n(!0)}catch(t){(0,e.R)(34,t),this.abortHandler?.(),(0,l.Ze)(this.agentIdentifier,this.featureName,!0),n(!1),this.ee&&this.ee.abort()}};p.RI?(0,g.GG)((()=>o()),!0):o()}#t(e,t){switch(e){case a.K7.sessionReplay:return m(this.agentIdentifier)&&!!t;case a.K7.sessionTrace:return!!t;default:return!0}}}var w=i(6630);class A extends y{static featureName=w.T;constructor(e,t=!0){super(e,w.T,t),this.importAggregator(e)}}var R=i(9908),E=i(2843),x=i(3878),_=i(782),N=i(1863);class T extends y{static featureName=_.T;constructor(e,t=!0){super(e,_.T,t),p.RI&&((0,E.u)((()=>(0,R.p)("docHidden",[(0,N.t)()],void 0,_.T,this.ee)),!0),(0,x.sp)("pagehide",(()=>(0,R.p)("winPagehide",[(0,N.t)()],void 0,_.T,this.ee))),this.importAggregator(e))}}var S=i(3969);class j extends y{static featureName=S.TZ;constructor(e,t=!0){super(e,S.TZ,t),this.importAggregator(e)}}new class extends o{constructor(t,r){super(r),p.gm?(this.features={},(0,h.bQ)(this.agentIdentifier,this),this.desiredFeatures=new Set(t.features||[]),this.desiredFeatures.add(A),this.runSoftNavOverSpa=[...this.desiredFeatures].some((e=>e.featureName===a.K7.softNav)),(0,d.j)(this,t,t.loaderType||"agent"),this.run()):(0,e.R)(21)}get config(){return{info:this.info,init:this.init,loader_config:this.loader_config,runtime:this.runtime}}run(){try{const t=u(this.agentIdentifier),r=[...this.desiredFeatures];r.sort(((e,t)=>a.P3[e.featureName]-a.P3[t.featureName])),r.forEach((r=>{if(!t[r.featureName]&&r.featureName!==a.K7.pageViewEvent)return;if(this.runSoftNavOverSpa&&r.featureName===a.K7.spa)return;if(!this.runSoftNavOverSpa&&r.featureName===a.K7.softNav)return;const n=function(e){switch(e){case a.K7.ajax:return[a.K7.jserrors];case a.K7.sessionTrace:return[a.K7.ajax,a.K7.pageViewEvent];case a.K7.sessionReplay:return[a.K7.sessionTrace];case a.K7.pageViewTiming:return[a.K7.pageViewEvent];default:return[]}}(r.featureName).filter((e=>!(e in this.features)));n.length>0&&(0,e.R)(36,{targetFeature:r.featureName,missingDependencies:n}),this.features[r.featureName]=new r(this)}))}catch(t){(0,e.R)(22,t);for(const e in this.features)this.features[e].abortHandler?.();const r=(0,h.Zm)();delete r.initializedAgents[this.agentIdentifier]?.api,delete r.initializedAgents[this.agentIdentifier]?.features,delete this.sharedAggregator;return r.ee.get(this.agentIdentifier).abort(),!1}}}({features:[A,T,j],loaderType:"lite"})})()})();</script> <link rel="canonical" href="https://news.alnylam.com/perspectives/articles/2023-year-review-ceo-yvonne-greenstreet-reflects-year-substantial-growth-and" /> <meta name="description" content="Alnylam CEO Yvonne Greenstreet reflects on the company's accomplishments in 2023 and highlights of the 2023 annual report." /> <meta property="og:url" content="https://news.alnylam.com/perspectives/articles/2023-year-review-ceo-yvonne-greenstreet-reflects-year-substantial-growth-and" /> <meta property="og:title" content="2023 Year in Review: CEO Yvonne Greenstreet Reflects on a Year of Substantial Growth and Progress | Alnylam® Newsroom" /> <meta property="og:description" content="Alnylam CEO Yvonne Greenstreet reflects on the company's accomplishments in 2023 and highlights of the 2023 annual report." /> <meta property="og:image" content="https://news.alnylam.com/sites/default/files/2024-04/Screenshot%202024-04-12%20at%207.00.08%E2%80%AFPM.png" /> <meta name="twitter:card" content="summary" /> <meta name="twitter:description" content="Alnylam CEO Yvonne Greenstreet reflects on the company's accomplishments in 2023 and highlights of the 2023 annual report." /> <meta name="twitter:title" content="2023 Year in Review: CEO Yvonne Greenstreet Reflects on a Year of Substantial Growth and Progress | Alnylam® Newsroom" /> <meta name="twitter:url" content="https://news.alnylam.com/perspectives/articles/2023-year-review-ceo-yvonne-greenstreet-reflects-year-substantial-growth-and" /> <meta name="twitter:image" content="https://news.alnylam.com/sites/default/files/2024-04/Screenshot%202024-04-12%20at%207.00.08%E2%80%AFPM.png" /> <meta name="Generator" content="Drupal 9 (https://www.drupal.org)" /> <meta name="MobileOptimized" content="width" /> <meta name="HandheldFriendly" content="true" /> <meta name="viewport" content="width=device-width, initial-scale=1.0" /> <link rel="icon" href="/sites/default/files/favicon.png" type="image/png" /> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:200,200i,300,300i,400,400i,600,600i,700,700i,900,900i" rel="stylesheet"> <link rel="stylesheet" media="all" href="/modules/custom/alnylam_search/css/alnylam_search.css?slvopr" /> <link rel="stylesheet" media="all" href="/core/themes/stable/css/core/assets/vendor/normalize-css/normalize.css?slvopr" /> <link rel="stylesheet" media="all" href="/core/themes/stable/css/core/normalize-fixes.css?slvopr" /> <link rel="stylesheet" media="all" href="/core/themes/classy/css/components/messages.css?slvopr" /> <link rel="stylesheet" media="all" href="https://cdn.jsdelivr.net/npm/bootstrap@3.4.1/dist/css/bootstrap.css" /> <link rel="stylesheet" media="all" href="/themes/custom/alnylam/css/slick.css?slvopr" /> <link rel="stylesheet" media="all" href="/themes/custom/alnylam/css/slick-theme.css?slvopr" /> <link rel="stylesheet" media="all" href="/themes/custom/alnylam/css/lity.min.css?slvopr" /> <link rel="stylesheet" media="all" href="/themes/custom/alnylam/css/common.css?slvopr" /> <link rel="stylesheet" media="all" href="/themes/custom/alnylam/css/style.css?slvopr" /> <link rel="stylesheet" media="all" href="/themes/custom/alnylam/css/navigation.css?slvopr" /> <link rel="stylesheet" media="all" href="/themes/custom/alnylam/css/header.css?slvopr" /> <link rel="stylesheet" media="all" href="/themes/custom/alnylam/css/superfish.css?slvopr" /> <link rel="stylesheet" media="all" href="/themes/custom/alnylam/css/style-responsive.css?slvopr" /> <link rel="stylesheet" media="all" href="/themes/custom/alnylam/css/custom.css?slvopr" /> <link rel="stylesheet" media="all" href="/themes/custom/alnylam/css/ipad.css?slvopr" /> <link rel="stylesheet" media="all" href="/themes/custom/alnylam/css/mobile.css?slvopr" /> </head> <body class="path-node page-node-type-article">  <noscript> <iframe src="https://www.googletagmanager.com/ns.html?id=GTM-WJ29M6J" height="0" width="0" style="display:none;visibility:hidden"></iframe> </noscript>  <script type="text/javascript"> window.whitelist_links = ["https:\/\/www.alnylam.com","http:\/\/www.alnylam.com","www.alnylam.com","alnylam.com"]; </script> <div class="ajax_loader"> <div class="ajax_loader_1"> <div class="pulse"></div> </div> </div> <div class="wrapper"> <div class="wrapper_inner"> <div class="header-wrapper"> <header class=" has_top scroll_header_top_area page_header stick menu_bottom scrolled_not_transparent with_border"> <div class="header_inner clearfix"> <div class="header_top_bottom_holder"> <div class="header_top clearfix" style=''> <div class="container"> <div class="d-flex top-nav-wrapper"> <div class="header_inner_left"> <div id="toggle" class="mobile_menu_button"> <span> <a></a> </span> </div> <div class="logo_wrapper"> <div class="q_logo"> <a itemprop="url" href="https://www.alnylam.com"> <img itemprop="image" class="normal" src="/themes/custom/alnylam/img/Logo_Alnylam_460-1.svg" alt="Logo"/> <img itemprop="image" class="mob-logo" src="/themes/custom/alnylam/img/mob-logo.svg" alt="Logo"/> <img itemprop="image" class="dark-mob-logo" src="/themes/custom/alnylam/img/dark-mobile-photo.svg" alt="Logo"/> </a> </div> </div> </div> <div class="main-menu-wrapper clearfix"> <nav class="main_menu drop_down"> <ul id="menu-main-menu" class="clearfix"> <li class="menu-item narrow"><a href="/"> <span>Investors</span> </a> <div class="second"> <div class="inner"> <ul> <li class="menu-item"><a href="https://investors.alnylam.com/"><span> Investors </span></a></li> <li class="menu-item"><a href="https://investors.alnylam.com/alny-stock-information"><span> Stock Information </span></a></li> <li class="menu-item"><a href="https://investors.alnylam.com/investor-toolkit"><span> Investors Toolkit </span></a></li> <li class="menu-item"><a href="https://investors.alnylam.com/events"><span> Events & Presentations </span></a></li> <li class="menu-item"><a href="https://investors.alnylam.com/financial-information"><span> Financial Information </span></a></li> <li class="menu-item"><a href="https://investors.alnylam.com/financial-information?sec=#sec_filings"><span> SEC Filings </span></a></li> <li class="menu-item"><a href="https://investors.alnylam.com/corporate-governance"><span> Corporate Governance </span></a></li> <li class="menu-item"><a href="https://investors.alnylam.com/analyst-coverage"><span> Analyst Coverage </span></a></li> <li class="menu-item"><a href="https://investors.alnylam.com/financial-statements"><span> Fundamentals </span></a></li> <li class="menu-item"><a href="https://investors.alnylam.com/ownership-profile"><span> Ownership Profile </span></a></li> <li class="menu-item"><a href="https://investors.alnylam.com/annual-meetings"><span> Annual Meetings </span></a></li> <li class="menu-item"><a href="https://investors.alnylam.com/press-releases"><span> Press Releases </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/our-science/capella-rnai-innovation/"><span> Capella (Scientific Presentations) </span></a></li> <li class="menu-item"><a href="https://investors.alnylam.com/faq"><span> FAQs </span></a></li> </ul></div></div></li> <li class="m3level menu-item narrow"><a href="/"> <span>Medical Professionals</span> </a> <div class="second"> <div class="inner"> <ul> <li class="menu-item"><a href="https://www.alnylam.com/medical-professional-resources"><span> For Medical Professionals </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/medical-professional-resources/genetic-testing-counseling"><span> Genetic Testing & Counseling </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/medical-professional-resources/early-access-program"><span> Early Access Program </span></a></li> <li class="p3level menu-sub-item menu-item"><a href="https://www.alnylam.com/medical-professional-resources/early-access-program/patisiran"><span> Patisiran Early Access </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/medical-publication-support"><span> Medical Publication Support </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/about-alnylam/investigator-initiated-studies"><span> Investigator Initiated Studies (IIS) </span></a></li> </ul></div></div></li> <li class="menu-item narrow"><a href="/"> <span>Patients</span> </a> <div class="second"> <div class="inner"> <ul> <li class="menu-item"><a href="https://www.alnylam.com/patients"><span> For Patients </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/patients/amyloidosis"><span> Amyloidosis </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/patients/porphyria"><span> Acute Hepatic Porphyria </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/patients/primary-hyperoxaluria"><span> Primary Hyperoxaluria </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/patients/patient-services"><span> Patient Services </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/patients/genetic-testing-and-counseling-program"><span> Genetic Testing and Counseling </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/patients/patient-advocacy"><span> Patient Advocacy </span></a></li> </ul></div></div></li> <li class="m3level menu-item narrow"><a href="/"> <span>Job Seekers</span> </a> <div class="second"> <div class="inner"> <ul> <li class="menu-item"><a href="https://www.alnylam.com/careers"><span> Careers </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/careers/working-at-alnylam"><span> Working at Alnylam </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/careers/our-culture"><span> Who We Are </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/careers/opportunities"><span> Career Opportunities </span></a></li> <li class="p3level menu-sub-item menu-item"><a href="https://jobs.alnylam.com/careers"><span> Search Jobs </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/about-alnylam/diversity-inclusion"><span> Diversity, Equity & Inclusion </span></a></li> </ul></div></div></li> <li class="menu-item narrow"><a href="/"> <span>Quick Links</span> </a> <div class="second"> <div class="inner"> <ul> <li class="menu-item"><a href="https://www.alnylam.com/alnylam-rnai-pipeline/clinical-trials"><span> Clinical Trials </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/about-alnylam/corporate-responsibility"><span> Corporate Responsibility </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/about-alnylam/diversity-inclusion"><span> Diversity, Equity & Inclusion </span></a></li> <li class="menu-item"><a href="https://investors.alnylam.com/press-releases"><span> Press Releases </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/our-science/capella-rnai-innovation/"><span> Capella (Scientific Presentations) </span></a></li> <li class="menu-item"><a href="https://www.rnaiscience.com/"><span> Medical Resources (RNAi Science) </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/contact-us"><span> Contact Us </span></a></li> </ul></div></div></li> <li class="menu-item narrow"><a href="/"> <span>Follow Us</span> </a> <div class="second"> <div class="inner"> <ul> <li class="menu-item"><a href="https://www.youtube.com/channel/UCUZReY0GSAJ1w-MULQb9_Rw"><span> Youtube </span></a></li> <li class="menu-item"><a href="https://facebook.com/alnylampharma"><span> Facebook </span></a></li> <li class="menu-item"><a href="https://twitter.com/alnylam"><span> X </span></a></li> <li class="menu-item"><a href="https://www.linkedin.com/company/alnylam-pharmaceuticals/"><span> LinkedIn </span></a></li> <li class="menu-item"><a href="https://www.instagram.com/alnylampharma/"><span> Instagram </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/signup-for-updates/"><span> Sign Up </span></a></li> </ul></div></div></li> </ul> </nav>  <ul id="global_languages"> <li id="selector_list"> <a href="#" id="language_selector"><img id="actual-lang" src="/themes/custom/alnylam/img/globe-desktop-nav.svg"><i class="fa fa-chevron-down" aria-hidden="true"></i> </a> <nav id="languages"> <div class=" row1"> <span class="label-text"> Global </span> <span class="link-text"> <a href="/">English</a> </span> </div> <div class="d-flex row2"> <ul class="left-col"> <li class="lang-au "> <span>Austria</span><a href="https://www.alnylam.com/alnylam-austria/" class="">Deutsch</a> </li> <li class="lang-be "> <span>Belgium</span><a href="https://www.alnylam.com/alnylam-belgium-dutch/" class="">Nederlands</a> <a href="https://www.alnylam.com/alnylam-belgium-french/" class="">Français</a> </li> <li class="lang-br "> <span>Brazil</span><a href="https://alnylam.com.br" class="">Português</a> </li> <li class="lang-ca "> <span>Canada</span><a href="https://www.alnylam.ca/fr/" class="">Français</a> <a href="https://www.alnylam.ca/" class="selected">English</a> </li> <li class="lang-cz "> <span>Czech Republic</span><a href="https://www.alnylam.com/alnylam-czech-republic/" class="">Čeština</a> </li> <li class="lang-da "> <span>Denmark</span><a href="https://www.alnylam.com/alnylam-denmark/" class="">Dansk</a> </li> <li class="lang-fr "> <span>France</span><a href="https://www.alnylam.fr/" class="">Français</a> </li> <li class="lang-de "> <span>Germany</span><a href="https://www.alnylam.de/" class="">Deutsch</a> </li> <li class="lang-ir "> <span>Ireland</span><a href="/alnylam-ireland">English</a> </li> <li class="lang-it "> <span>Italy</span><a href="https://www.alnylam.it/" class="">Italiano</a> </li> </ul> <ul class="right-col"> <li class="lang-jp "> <span>Japan</span><a href="https://www.alnylam.jp/">日本語</a> </li> <li class="lang-lu "> <span>Luxembourg</span><a href="https://www.alnylam.com/alnylam-luxembourg-french/" class="">Français</a> <a href="https://www.alnylam.com/alnylam-luxembourg-german/" class="">Deutsch</a> </li> <li class="lang-nl "> <span>Netherlands</span><a href="https://www.alnylam.com/alnylam-netherlands/" class="">Nederlands</a> </li> <li class="lang-pt "> <span>Portugal</span><a href="https://www.alnylam.com/alnylam-portugal/" class="">Português</a> </li> <li class="lang-es "> <span>Spain</span><a href="https://www.alnylam.com/alnylam-espana/" class="">Español</a> </li> <li class="lang-sv "> <span>Sweden</span><a href="https://www.alnylam.com/alnylam-sverige/" class="">Svenska</a> </li> <li class="lang-ch "> <span>Switzerland</span><a href="https://www.alnylam.com/alnylam-switzerland-french/" class="">Français</a> <a href="https://www.alnylam.com/alnylam-switzerland-german/" class="" style="margin: 0px 0px 0px 2px;">Deutsch</a> <a href="https://www.alnylam.com/alnylam-switzerland-italian/" class="" style="margin: 0px 0px 0px 7px;">Italiano</a> </li> <li class="lang-tw "> <span>Taiwan</span><a href="https://www.alnylam.com/alnylam-taiwan/" class="selected">繁體中文</a> </li> <li class="lang-uk "> <span>United Kingdom</span><a href="https://www.alnylam.com/alnylam-uk/" class="selected">English</a> </li> </ul> <div class="clear-nav"></div> </div> </nav> </li> </ul> </div> </div> </div> </div> <div class="header_bottom clearfix" style=''> <div class="container"> <div class="container_inner clearfix"> <div class="header_menu_bottom"> <div class="header_menu_bottom_inner d-flex"> <div class="down-menu-wrapper"> <nav class="main_menu drop_down"> <ul id="menu-main-menu-1" class="clearfix"> <li class="m3level menu-item narrow"><a href="/"> <span>Our Company</span> </a> <div class="second"> <div class="inner"> <ul> <li class="menu-item"><a href="https://www.alnylam.com/about-alnylam"><span> About Alnylam </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/about-alnylam/alnylam-leadership"><span> Leadership </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/about-alnylam/diversity-inclusion"><span> Diversity, Equity & Inclusion </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/about-alnylam/patient-access-philosophy"><span> Patient Access Philosophy </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/about-alnylam/corporate-responsibility"><span> Corporate Responsibility </span></a></li> <li class="p3level menu-sub-item menu-item"><a href="https://www.alnylam.com/about-alnylam/transparency"><span> Transparency </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/about-alnylam/grants-and-giving"><span> Grants & Giving </span></a></li> <li class="p3level menu-sub-item menu-item"><a href="https://www.alnylam.com/about-alnylam/grants-and-giving/advocacy-for-impact-grants"><span> Advocacy for Impact Grants </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/about-alnylam/investigator-initiated-studies"><span> Investigator Initiated Studies (IIS) </span></a></li> </ul></div></div></li> <li class="m3level menu-item narrow"><a href="/"> <span>Our Science</span> </a> <div class="second"> <div class="inner"> <ul> <li class="menu-item"><a href="https://www.alnylam.com/our-science/the-science-of-rnai"><span> The Science of RNAi </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/our-science/sirna-delivery-platforms"><span> Delivery Platforms </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/alnylam-rnai-pipeline"><span> Therapeutic Areas </span></a></li> <li class="p3level menu-sub-item menu-item"><a href="https://www.alnylam.com/alnylam-rnai-pipeline"><span> Pipeline </span></a></li> <li class="p3level menu-sub-item menu-item"><a href="https://www.alnylam.com/alnylam-rnai-pipeline/clinical-trials"><span> Clinical Trials </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/our-science/alnylam-scientific-advisory-board"><span> Scientific Advisory Board </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/our-science/intellectual-property"><span> Intellectual Property </span></a></li> <li class="menu-item"><a href="https://capella.alnylam.com/our-science/capella-rnai-innovation/"><span> Capella (Scientific Presentations) </span></a></li> </ul></div></div></li> <li class="menu-item narrow"><a href="/"> <span>Our Products</span> </a> <div class="second"> <div class="inner"> <ul> <li class="menu-item"><a href="https://www.alnylam.com/our-products"><span> Product Listing </span></a></li> </ul></div></div></li> <li class="menu-item narrow"><a href="/"> <span>Our News</span> </a> <div class="second"> <div class="inner"> <ul> <li class="menu-item"><a href="/"><span> Newsroom </span></a></li> <li class="menu-item"><a href="https://investors.alnylam.com/press-releases"><span> Press Releases </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/our-science/capella-rnai-innovation/"><span> Capella (Scientific Presentations) </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/media-kit"><span> Media Kit </span></a></li> </ul></div></div></li> </ul> </nav> </div> <ul id="global_languages" class="mobile-language"> <li id="selector_list"> <a href="#" id="language_selector_1"><img id="actual-lang" src="/themes/custom/alnylam/img/language.png"> <img id="dark_lang" src="/themes/custom/alnylam/img/globe-white.svg"><i class="fa fa-chevron-down" aria-hidden="true"></i> </a> <nav id="languages" style="display: none;"> <div class=" row1"> <span class="label-text"> Global </span> <span class="link-text"> <a href="/">English</a> </span> </div> <div class="d-flex row2"> <ul class="left-col"> <li class="lang-au "> <span>Austria</span><a href="https://www.alnylam.com/alnylam-austria/" class="">Deutsch</a> </li> <li class="lang-be "> <span>Belgium</span><a href="https://www.alnylam.com/alnylam-belgium-dutch/" class="">Nederlands</a> <a href="https://www.alnylam.com/alnylam-belgium-french/" class="">Français</a> </li> <li class="lang-br "> <span>Brazil</span><a href="https://alnylam.com.br" class="">Português</a> </li> <li class="lang-ca "> <span>Canada</span><a href="https://www.alnylam.ca/fr/" class="">Français</a> <a href="https://www.alnylam.ca/" class="selected">English</a> </li> <li class="lang-cz "> <span>Czech Republic</span><a href="https://www.alnylam.com/alnylam-czech-republic/" class="">Čeština</a> </li> <li class="lang-da "> <span>Denmark</span><a href="https://www.alnylam.com/alnylam-denmark/" class="">Dansk</a> </li> <li class="lang-fr "> <span>France</span><a href="https://www.alnylam.fr/" class="">Français</a> </li> <li class="lang-de "> <span>Germany</span><a href="https://www.alnylam.de/" class="">Deutsch</a> </li> <li class="lang-ir "> <span>Ireland</span><a href="/alnylam-ireland">English</a> </li> <li class="lang-it "> <span>Italy</span><a href="https://www.alnylam.it/" class="">Italiano</a> </li> </ul> <ul class="right-col"> <li class="lang-jp "> <span>Japan</span><a href="https://www.alnylam.jp/">日本語</a> </li> <li class="lang-lu "> <span>Luxembourg</span><a href="https://www.alnylam.com/alnylam-luxembourg-french/" class="">Français</a> <a href="https://www.alnylam.com/alnylam-luxembourg-german/" class="">Deutsch</a> </li> <li class="lang-nl "> <span>Netherlands</span><a href="https://www.alnylam.com/alnylam-netherlands/" class="">Nederlands</a> </li> <li class="lang-pt "> <span>Portugal</span><a href="https://www.alnylam.com/alnylam-portugal/" class="">Português</a> </li> <li class="lang-es "> <span>Spain</span><a href="https://www.alnylam.com/alnylam-espana/" class="">Español</a> </li> <li class="lang-sv "> <span>Sweden</span><a href="https://www.alnylam.com/alnylam-sverige/" class="">Svenska</a> </li> <li class="lang-ch "> <span>Switzerland</span><a href="https://www.alnylam.com/alnylam-switzerland-french/" class="">Français</a> <a href="https://www.alnylam.com/alnylam-switzerland-german/" class="" style="margin: 0px 0px 0px 2px;">Deutsch</a> <a href="https://www.alnylam.com/alnylam-switzerland-italian/" class="" style="margin: 0px 0px 0px 7px;">Italiano</a> </li> <li class="lang-tw "> <span>Taiwan</span><a href="https://www.alnylam.com/alnylam-taiwan/" class="selected">繁體中文</a> </li> <li class="lang-uk "> <span>United Kingdom</span><a href="https://www.alnylam.com/alnylam-uk/" class="selected">English</a> </li> </ul> <div class="clear-nav"></div> </div> </nav> </li> </ul> <div class="header_inner_right"> <div class="region region-header-bottom-right"> <div id="block-basicsearchblock" class="block block-alnylam-search block-basic-search-block"> <div class="alnylam__basic-search-block"> <form action="/search-results" method="GET"> <div id="search-input" class="input-group hide"> <input type="text" name="keyword" placeholder="Type something"/> <button type="submit">search</button> </div> <button type="button" id="search-open-btn"><img src="/modules/custom/alnylam_search/images/search.svg"></button> <button type="button" id="search-close-btn" class="hide"><img src="/modules/custom/alnylam_search/images/search.svg"></button> </form> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> <div class="mobile-menu-container"> <nav class="main_menu drop_down"> <ul id="menu-main-menu-1" class="clearfix"> <li class="m3level menu-item narrow"><a href="/"> <span>Our Company</span> </a> <div class="second"> <div class="inner"> <ul> <li class="menu-item"><a href="https://www.alnylam.com/about-alnylam"><span> About Alnylam </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/about-alnylam/alnylam-leadership"><span> Leadership </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/about-alnylam/diversity-inclusion"><span> Diversity, Equity & Inclusion </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/about-alnylam/patient-access-philosophy"><span> Patient Access Philosophy </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/about-alnylam/corporate-responsibility"><span> Corporate Responsibility </span></a></li> <li class="p3level menu-sub-item menu-item"><a href="https://www.alnylam.com/about-alnylam/transparency"><span> Transparency </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/about-alnylam/grants-and-giving"><span> Grants & Giving </span></a></li> <li class="p3level menu-sub-item menu-item"><a href="https://www.alnylam.com/about-alnylam/grants-and-giving/advocacy-for-impact-grants"><span> Advocacy for Impact Grants </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/about-alnylam/investigator-initiated-studies"><span> Investigator Initiated Studies (IIS) </span></a></li> </ul></div></div></li> <li class="m3level menu-item narrow"><a href="/"> <span>Our Science</span> </a> <div class="second"> <div class="inner"> <ul> <li class="menu-item"><a href="https://www.alnylam.com/our-science/the-science-of-rnai"><span> The Science of RNAi </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/our-science/sirna-delivery-platforms"><span> Delivery Platforms </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/alnylam-rnai-pipeline"><span> Therapeutic Areas </span></a></li> <li class="p3level menu-sub-item menu-item"><a href="https://www.alnylam.com/alnylam-rnai-pipeline"><span> Pipeline </span></a></li> <li class="p3level menu-sub-item menu-item"><a href="https://www.alnylam.com/alnylam-rnai-pipeline/clinical-trials"><span> Clinical Trials </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/our-science/alnylam-scientific-advisory-board"><span> Scientific Advisory Board </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/our-science/intellectual-property"><span> Intellectual Property </span></a></li> <li class="menu-item"><a href="https://capella.alnylam.com/our-science/capella-rnai-innovation/"><span> Capella (Scientific Presentations) </span></a></li> </ul></div></div></li> <li class="menu-item narrow"><a href="/"> <span>Our Products</span> </a> <div class="second"> <div class="inner"> <ul> <li class="menu-item"><a href="https://www.alnylam.com/our-products"><span> Product Listing </span></a></li> </ul></div></div></li> <li class="menu-item narrow"><a href="/"> <span>Our News</span> </a> <div class="second"> <div class="inner"> <ul> <li class="menu-item"><a href="/"><span> Newsroom </span></a></li> <li class="menu-item"><a href="https://investors.alnylam.com/press-releases"><span> Press Releases </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/our-science/capella-rnai-innovation/"><span> Capella (Scientific Presentations) </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/media-kit"><span> Media Kit </span></a></li> </ul></div></div></li> </ul> </nav> <div class="second-mobile-menu"> <div class="container_inner"> <nav class="mobile_menu"> <ul> <li class="menu-item has_sub"> <p>Investors</p> <a class="d-none hide" href="/">Investors</a> <span class="mobile_arrow"></span> <ul class="sub_menu"> <li class="menu-item"><a href="https://investors.alnylam.com/"><span> Investors </span></a></li> <li class="menu-item"><a href="https://investors.alnylam.com/alny-stock-information"><span> Stock Information </span></a></li> <li class="menu-item"><a href="https://investors.alnylam.com/investor-toolkit"><span> Investors Toolkit </span></a></li> <li class="menu-item"><a href="https://investors.alnylam.com/events"><span> Events & Presentations </span></a></li> <li class="menu-item"><a href="https://investors.alnylam.com/financial-information"><span> Financial Information </span></a></li> <li class="menu-item"><a href="https://investors.alnylam.com/financial-information?sec=#sec_filings"><span> SEC Filings </span></a></li> <li class="menu-item"><a href="https://investors.alnylam.com/corporate-governance"><span> Corporate Governance </span></a></li> <li class="menu-item"><a href="https://investors.alnylam.com/analyst-coverage"><span> Analyst Coverage </span></a></li> <li class="menu-item"><a href="https://investors.alnylam.com/financial-statements"><span> Fundamentals </span></a></li> <li class="menu-item"><a href="https://investors.alnylam.com/ownership-profile"><span> Ownership Profile </span></a></li> <li class="menu-item"><a href="https://investors.alnylam.com/annual-meetings"><span> Annual Meetings </span></a></li> <li class="menu-item"><a href="https://investors.alnylam.com/press-releases"><span> Press Releases </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/our-science/capella-rnai-innovation/"><span> Capella (Scientific Presentations) </span></a></li> <li class="menu-item"><a href="https://investors.alnylam.com/faq"><span> FAQs </span></a></li> </ul></li> <li class="menu-item m3level has_sub"> <p>Medical Professionals</p> <a class="d-none hide" href="/">Medical Professionals</a> <span class="mobile_arrow"></span> <ul class="sub_menu"> <li class="menu-item"><a href="https://www.alnylam.com/medical-professional-resources"><span> For Medical Professionals </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/medical-professional-resources/genetic-testing-counseling"><span> Genetic Testing & Counseling </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/medical-professional-resources/early-access-program"><span> Early Access Program </span></a></li> <li class="p3level menu-sub-item menu-item"><a href="https://www.alnylam.com/medical-professional-resources/early-access-program/patisiran"><span> Patisiran Early Access </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/medical-publication-support"><span> Medical Publication Support </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/about-alnylam/investigator-initiated-studies"><span> Investigator Initiated Studies (IIS) </span></a></li> </ul></li> <li class="menu-item has_sub"> <p>Patients</p> <a class="d-none hide" href="/">Patients</a> <span class="mobile_arrow"></span> <ul class="sub_menu"> <li class="menu-item"><a href="https://www.alnylam.com/patients"><span> For Patients </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/patients/amyloidosis"><span> Amyloidosis </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/patients/porphyria"><span> Acute Hepatic Porphyria </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/patients/primary-hyperoxaluria"><span> Primary Hyperoxaluria </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/patients/patient-services"><span> Patient Services </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/patients/genetic-testing-and-counseling-program"><span> Genetic Testing and Counseling </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/patients/patient-advocacy"><span> Patient Advocacy </span></a></li> </ul></li> <li class="menu-item m3level has_sub"> <p>Job Seekers</p> <a class="d-none hide" href="/">Job Seekers</a> <span class="mobile_arrow"></span> <ul class="sub_menu"> <li class="menu-item"><a href="https://www.alnylam.com/careers"><span> Careers </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/careers/working-at-alnylam"><span> Working at Alnylam </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/careers/our-culture"><span> Who We Are </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/careers/opportunities"><span> Career Opportunities </span></a></li> <li class="p3level menu-sub-item menu-item"><a href="https://jobs.alnylam.com/careers"><span> Search Jobs </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/about-alnylam/diversity-inclusion"><span> Diversity, Equity & Inclusion </span></a></li> </ul></li> <li class="menu-item has_sub"> <p>Quick Links</p> <a class="d-none hide" href="/">Quick Links</a> <span class="mobile_arrow"></span> <ul class="sub_menu"> <li class="menu-item"><a href="https://www.alnylam.com/alnylam-rnai-pipeline/clinical-trials"><span> Clinical Trials </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/about-alnylam/corporate-responsibility"><span> Corporate Responsibility </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/about-alnylam/diversity-inclusion"><span> Diversity, Equity & Inclusion </span></a></li> <li class="menu-item"><a href="https://investors.alnylam.com/press-releases"><span> Press Releases </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/our-science/capella-rnai-innovation/"><span> Capella (Scientific Presentations) </span></a></li> <li class="menu-item"><a href="https://www.rnaiscience.com/"><span> Medical Resources (RNAi Science) </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/contact-us"><span> Contact Us </span></a></li> </ul></li> <li class="menu-item has_sub"> <p>Follow Us</p> <a class="d-none hide" href="/">Follow Us</a> <span class="mobile_arrow"></span> <ul class="sub_menu"> <li class="menu-item"><a href="https://www.youtube.com/channel/UCUZReY0GSAJ1w-MULQb9_Rw"><span> Youtube </span></a></li> <li class="menu-item"><a href="https://facebook.com/alnylampharma"><span> Facebook </span></a></li> <li class="menu-item"><a href="https://twitter.com/alnylam"><span> X </span></a></li> <li class="menu-item"><a href="https://www.linkedin.com/company/alnylam-pharmaceuticals/"><span> LinkedIn </span></a></li> <li class="menu-item"><a href="https://www.instagram.com/alnylampharma/"><span> Instagram </span></a></li> <li class="menu-item"><a href="https://www.alnylam.com/signup-for-updates/"><span> Sign Up </span></a></li> </ul></li> </ul> </nav> </div> </div> <div class="flow-us"> <div class="d-flex"> <a target="_blank" href="https://www.youtube.com/channel/UCUZReY0GSAJ1w-MULQb9_Rw" class="flow-icon"> <img class="img-fluid" src="/themes/custom/alnylam/img/social-icons/mobile-youtube.svg"> </a> <a target="_blank" href="https://www.facebook.com/AlnylamPharma/" class="flow-icon"> <img class="img-fluid" src="/themes/custom/alnylam/img/social-icons/facebook.svg"> </a> <a target="_blank" href="https://twitter.com/alnylam" class="flow-icon"> <img class="img-fluid" src="/themes/custom/alnylam/img/social-icons/twitter-x.svg"> </a> <a target="_blank" href="https://www.linkedin.com/company/alnylam-pharmaceuticals/" class="flow-icon"> <img class="img-fluid" src="/themes/custom/alnylam/img/social-icons/mobile-likedin.png"> </a> <a target="_blank" href="https://www.instagram.com/alnylampharma/" class="flow-icon"> <img class="img-fluid" src="/themes/custom/alnylam/img/social-icons/mobile-instagram.svg"> </a> </div> </div> </div> </header> </div> <a id='back_to_top' href='#'> <span class="fa-stack"> <i class="fa fa-arrow-up" style=""></i> </span> </a> <main class="content" style="margin-top: 0px;"> <div class="dialog-off-canvas-main-canvas" data-off-canvas-main-canvas> <div id="hero"> <img src="/sites/default/files/2024-04/Screenshot%202024-04-12%20at%207.00.08%E2%80%AFPM.png" /> </div> <div id="content_inner"> <div class="single standard sidebar" > <div class="article_body"> <div class="eyebrown-head"> <p class="mobile-eyebrow"><span class="our-news">Our News</span></p> <div class="share share-mobile"> <div class="social_links-container"> <a href="#" class="icons-action"><h4>Share this:</h4><img src="/sites/default/files/media-icons/icon-share-all.svg" /></a> </div> <div class="social_links"> <a class="facebook internal" href="#"><span class="fa fa-facebook"></span></a> <a class="twitter internal" href="#"><span class="fa-brands fa-x-twitter"></span></a> <a class="linkedin internal" href="#"><span class="fa fa-linkedin"></span></a> <a class="email internal" href="#"><span class="fa fa-envelope-o"></span></a> </div> </div> </div> <h2 class="page_title">2023 Year in Review: CEO Yvonne Greenstreet Reflects on a Year of Substantial Growth and Progress</h2> <div class="subline"></div> <p class="date">April 2, 2024</p> <a href="/author/ygreenestreet"> <div class="author"> <img src="https://news.alnylam.com/sites/default/files/2024-04/Yvonne%20Greenstreet%20Alnylam%20Official%201.jpg" /> <h4 class="name">Dr. Yvonne Greenstreet</h4> <h4 class="role"> Chief Executive Officer, Alnylam Pharmaceuticals </h4> </div> </a> <p>2023 was a year marked by a strong financial performance, excellent commercial execution, and exciting advances in our pipeline and platform. Most importantly, we helped to transform the lives of more than 5,000 patients around the world with our medicines.</p> <p>I am so excited about Alnylam and the enormous promise we hold. We have come far in our quest to transform the extraordinary science of RNA interference into a new class of medicines, but we are only just beginning. In the near term, we are on track to meet the five-year goals we laid out in our <i>Alnylam P<sup>5</sup> X 25 strategy</i>. These goals reflect our ambition to establish ourselves as a top-tier biotechnology company and increase the value we deliver to our shareholders and to society.</p> <p>I'm pleased to note some highlights from last year that underscore the strong progress we made across our business below and invite you to read more in our <a href="https://bit.ly/3VSdzFm">2023 annual report</a>.</p> <p><strong>Continued Commercial Success </strong><span style="font-size:11.0pt"><span style="line-height:107%"><span style="font-family:"Calibri",sans-serif"><strong>–</strong> </span></span></span>We <a href="https://investors.alnylam.com/press-release?id=27941">achieved $1.2 billion in global net product revenues</a><span style="color:black">, an increase of 39 percent compared with the previous year. This growth was driven by increasing demand within our portfolio of products—ONPATTRO<sup>® </sup>(patisiran), AMVUTTRA<sup>® </sup>(vutrisiran), GIVLAARI<sup>® </sup>(givosiran), and OXLUMO<sup>®</sup> (lumasiran)—along with strong commercial execution by our teams in delivering these important medicines to patients in need globally. Royalty revenue also increased, as sales of Leqvio<sup>®</sup> (inclisiran), an Alnylam-discovered RNAi-therapeutic marketed by Novartis in nearly 100 countries, continued to grow steadily.</span></p> <p><span style="color:black"><img alt="African American male leaning on railing" data-entity-type="file" data-entity-uuid="d9116df8-cae5-450e-83d0-407a4e0a135e" src="/sites/default/files/inline-images/Alnylam%20Annual%20Reflection%202023%201.png" /></span></p> <p><strong>On a Path to Sustained Profitability </strong><span style="font-size:11.0pt"><span style="line-height:107%"><span style="font-family:"Calibri",sans-serif"><strong>–</strong> </span></span></span>We ended the year with a cash and investment balance of approximately $2.4 billion and moved closer to achieving our goal of sustained profitability by the end of 2025. Delivering ongoing profitable growth will enable us to continue to build the company, realize the huge promise of our pipeline, and deliver breakthrough medicines for patients for many years to come.</p> <p><strong>Advancing our Clinical Pipeline <span style="font-size:11.0pt"><span style="line-height:107%"><span style="font-family:"Calibri",sans-serif">–</span></span></span></strong> We also made strong progress in advancing potential new medicines across our rapidly expanding pipeline.</p> <ul> <li style="margin-bottom: 11px;">This includes zilebisiran, an investigational RNAi therapeutic in development to treat hypertension in patients at high cardiovascular risk. We <a href="https://investors.alnylam.com/press-release?id=27706">reported positive topline results</a> from the KARDIA-1 Phase 2 study of zilebisiran, building on results from the Phase 1 study, which were <a href="https://investors.alnylam.com/press-release?id=27601">published in the New England Journal of Medicine</a>.</li> <li style="margin-bottom: 11px;">We also entered into an <a href="https://investors.alnylam.com/press-release?id=27611">exciting strategic partnership with Roche</a>, which will allow us to develop zilebisiran in a more robust way, benefit from Roche’s global footprint and experience in developing and commercializing therapies in complex markets, and ultimately reach <span style="color:black">as many patients as possible.</span></li> <li style="margin-bottom: 14px;">In addition, we shared encouraging early findings for several other programs targeting more prevalent diseases. We <a href="https://investors.alnylam.com/press-release?id=27761">reported positive interim results</a> for the ongoing Phase 1 study of ALN-APP in patients with early-onset Alzheimer’s disease, the first ever clinical demonstration of gene silencing in the human brain using an RNAi therapeutic. We also reported positive initial Phase 1 data for ALN-KHK, an exciting investigational RNAi therapeutic in development for the treatment of type 2 diabetes mellitus, an area of continued unmet need globally.</li> </ul> <p><strong>Looking forward in ATTR Amyloidosis –</strong> While we made great progress across our clinical pipeline last year, we were disappointed to receive a <a href="https://investors.alnylam.com/press-release?id=27741">Complete Response Letter</a> for patisiran for the treatment of cardiomyopathy of ATTR amyloidosis. We remain deeply committed to patients with this disease and look forward to reporting topline results from the Phase 3 HELIOS-B study evaluating vutrisiran for this indication this year. Our ambition is to establish Alnylam as the leader in the treatment of ATTR amyloidosis and <span style="background:white"><span style="color:black">vutrisiran as THE rapid knockdown therapy for patients with </span></span><span style="color:black">all forms of ATTR amyloidosis.</span></p> <p><span style="color:black"><img alt="Alnylam scientists in the laboratory" data-entity-type="file" data-entity-uuid="c0374f91-a15c-491d-9cea-83d7bda22311" src="/sites/default/files/inline-images/Alnylam%20sciientists%20in%20the%20lab.png" /></span></p> <p><strong>Our Sustainable Innovation Engine –</strong> At our annual R&D Day, <a href="https://investors.alnylam.com/press-release?id=27841">we highlighted important advances</a> in our RNAi platform supporting our goal to deliver therapeutics to many new tissues in the body, including adipose tissue and muscle tissue and and tumors, allowing us to broadly expand the range of diseases we aim to treat. Given these advances in our platform, we anticipate doubling the size of our clinical pipeline by the end of next year, as we look to file Investigational New Drug (IND) applications for nine new programs, supplemented by an additional six IND applications from our partners.</p> <p><strong>Our People and Culture – </strong>As we grow, we continue to focus on the foundation and heart of Alnylam: our culture and people. We are keen to sustain our entrepreneurial ‘challenge-accepted’ spirit as we build the company to operate effectively on a larger scale. We also aim to be a global leader in diversity, equity, and inclusion and to build an exceptional workplace that inspires and attracts innovative and ambitious people dedicated to advancing breakthrough medicines that transform lives and solve major healthcare challenges. We were recognized again this year as a top place to work by numerous publications, including <em><a href="https://www.bostonglobe.com/2023/11/29/magazine/no-1-largest-company-alnylam-pharmaceuticals/">The Boston Globe</a></em> and <a href="https://news.alnylam.com/careers-culture/articles/alnylam-named-top-science-employer-science-magazine-5th-year-row"><em>Science</em> magazine</a>, while also being certified as a Great Place to Work in ten countries and ranking among <em>Fortune’s</em> Best Workplaces for Women and included on the<em> </em><a href="https://news.alnylam.com/careers-culture/articles/alnylam-named-bloombergs-gender-equality-index-3rd-year-row"><em>Bloomberg</em> Gender-Equality Index</a>.</p> <p><img alt="Alnylam employees volunteering" data-entity-type="file" data-entity-uuid="67ff2237-f07e-4d06-a6d7-ed92a4c69076" src="/sites/default/files/inline-images/Alnylam%20employees%20volunteering.png" /></p> <p><strong>Our Corporate Responsibility –</strong> We continued to earn recognition for our corporate responsibility efforts. We were included on <a href="https://news.alnylam.com/responsibility/articles/alnylam-named-one-americas-most-responsible-companies-newsweek-2nd-year-row"><em>Newsweek’s</em> list of America’s Most Socially Responsible Companies</a> and maintained our ‘A’ ESG rating with MSCI. We outlined our strong commitment in this area with the release of our third <a href="https://www.alnylam.com/sites/default/files/pdfs/2022%20Alnylam%20Corporate%20Responsibility%20Report.pdf">Corporate Responsibility Report</a>, which described our efforts to enable broad access to our medicines, highlighted our entrepreneurial and community partnerships that are addressing health inequities, and detailed the progress we have made in reducing our environmental impact.</p> <p>Alnylam continues to lead the wave of RNAi innovation that is changing medicine. I am so excited about our future and the enormous promise we hold to change the lives of patients around the world. As we look ahead to next year and the years to come, I feel that we are at just the beginning of an extraordinary journey.</p> <p><a href="https://bit.ly/3VSdzFm"><img alt="Download Alnylam's 2023 Annual Report " data-entity-type="file" data-entity-uuid="5804849a-a07e-421b-8475-129eacfb7333" src="/sites/default/files/inline-images/Alnylam%202023%20Annual%20Report%20Thumbnail.png" /></a></p> <p> </p> <div class="footnote"> </div> <div class="tags"> <h4>Tags</h4> <p> <a href="/category/perspectives">Perspectives</a>, <a href="/type/articles">Articles</a>, <a href="/tag/annual-report">Annual Report</a> </p> </div> <div class="related mobile-only"> <h5>Related Content <a href="/" class="allcontent relatedlink topmobile"><span>See All News ›</span></a></h5> <div class="articles"> <div class="view"> <div class="article_wrapper" style="background: url('https://news.alnylam.com/sites/default/files/2024-10/ALNY%20PIN%20Newsroom%20Article%20Thumbnail.png') no-repeat;"> <a href="/perspectives/articles/better-together-collaborating-rare-disease-care-pharmacy-innovation-network"> <div class="article"> <span class="category">Perspectives</span> <span class="excerpt">Better Together: Collaborating for Rare Disease Care, Pharmacy Innovation Network</span> </div> </a> </div> <div class="article_wrapper" style="background: url('https://news.alnylam.com/sites/default/files/2024-04/Alnyalm%20Health%20System%20Article%20Thumbnail.png') no-repeat;"> <a href="/perspectives/articles/better-together-alnylam-and-organized-customer-health-systems-want-improve"> <div class="article"> <span class="category">Perspectives</span> <span class="excerpt">Better Together: Alnylam and Organized Customer Health Systems Want to Improve Access a ...</span> </div> </a> </div> <div class="article_wrapper" style="background: url('https://news.alnylam.com/sites/default/files/2023-04/Norton%20Apr%2023%20for%20Newsroom%20Thumb.png') no-repeat;"> <a href="/perspectives/articles/2022-annual-report-ceo-yvonne-greenstreet-reflects-next-chapter-rnai"> <div class="article"> <span class="category">Perspectives</span> <span class="excerpt">2022 Annual Report: CEO Yvonne Greenstreet Reflects on the Next Chapter in the RNAi Rev ...</span> </div> </a> </div> </div> </div> </div> </div> <div class="sidebar "> <div class="share"> <h4>Share this:</h4> <div class="social_links"> <a class="facebook internal" href="#"><span class="fa fa-facebook"></span></a> <a class="twitter internal" href="#"><span class="fa-brands fa-x-twitter"></span></a> <a class="linkedin internal" href="#"><span class="fa fa-linkedin"></span></a> <a class="email internal" href="#"><span class="fa fa-envelope-o"></span></a> </div> </div> <div class="navigation"> <div class="terms" style="margin-bottom: 50px;"> <h4>Categories</h4> <ul> <li class=""><a href="/category/leadership">Leadership</a> </li> <li class="active"><a href="/category/perspectives">Perspectives</a> </li> <li class=""><a href="/category/rnai">RNAi</a> </li> <li class=""><a href="/category/patient-focus">Patient Focus</a> </li> <li class=""><a href="/category/responsibility">Responsibility</a> </li> <li class=""><a href="/category/careers-culture">Careers & Culture</a> </li> </ul> </div> <div class="terms"> <h4>Content Types</h4> <ul> <li class="active"><a href="/type/articles">Articles</a> </li> <li class=""><a href="/type/podcasts">Podcasts</a> </li> <li class=""><a href="/type/presentations">Presentations</a> </li> <li class=""><a href="/type/videos">Videos</a> </li> </ul> </div> <div class="allcontent sidelink"><a href="/"><span>See All News ›</span></a></div> </div> </div> </div> <div class="related"> <h5>Related Content <a href="/" class="allcontent relatedlink desktop"><span>See All News ›</span></a></h5> <div class="articles"> <div class="view"> <div class="article_wrapper" style="background: url('https://news.alnylam.com/sites/default/files/2024-10/ALNY%20PIN%20Newsroom%20Article%20Thumbnail.png') no-repeat;"> <a href="/perspectives/articles/better-together-collaborating-rare-disease-care-pharmacy-innovation-network"> <div class="article"> <span class="category">Perspectives</span> <span class="excerpt">Better Together: Collaborating for Rare Disease Care, Pharmacy Innovation Network</span> </div> </a> </div> <div class="article_wrapper" style="background: url('https://news.alnylam.com/sites/default/files/2024-04/Alnyalm%20Health%20System%20Article%20Thumbnail.png') no-repeat;"> <a href="/perspectives/articles/better-together-alnylam-and-organized-customer-health-systems-want-improve"> <div class="article"> <span class="category">Perspectives</span> <span class="excerpt">Better Together: Alnylam and Organized Customer Health Systems Want to Improve Access a ...</span> </div> </a> </div> <div class="article_wrapper" style="background: url('https://news.alnylam.com/sites/default/files/2023-04/Norton%20Apr%2023%20for%20Newsroom%20Thumb.png') no-repeat;"> <a href="/perspectives/articles/2022-annual-report-ceo-yvonne-greenstreet-reflects-next-chapter-rnai"> <div class="article"> <span class="category">Perspectives</span> <span class="excerpt">2022 Annual Report: CEO Yvonne Greenstreet Reflects on the Next Chapter in the RNAi Rev ...</span> </div> </a> </div> </div>  <div class="bottomlink"><a href="/" class="allcontent relatedlink bottommobile"><span>See All News ›</span></a></div> </div> </div> </div> </div> </main> <section class="new-footer"> <div class="top-dna-lines"> <div class="footer-dna-lines"> <div class="footer-container"> <div class="d-flex"> <div> <h2 class="footer-header">FOLLOW US</h2> <p class="footer-description"> Visit our social channels to learn more about the innovative work we are doing at Alnylam. </p> </div> <div class="right-icons d-flex"> <a target="_blank" href="https://www.youtube.com/channel/UCUZReY0GSAJ1w-MULQb9_Rw" ><img loading="eager" src="/sites/default/files/inline-images/youtube_icon.svg" /></a> <a target="_blank" href="https://www.facebook.com/AlnylamPharma/" ><img loading="eager" src="/sites/default/files/inline-images/fb_icon.svg" /></a> <a target="_blank" href="https://twitter.com/alnylam" ><img loading="eager" src="/sites/default/files/inline-images/x_icon.svg" /></a> <a target="_blank" href="https://www.linkedin.com/company/alnylam-pharmaceuticals/" ><img loading="eager" src="/sites/default/files/inline-images/linkedin_icon.svg" /></a> <a target="_blank" href="https://www.instagram.com/alnylampharma/" ><img loading="eager" src="/sites/default/files/inline-images/instagram_icon.svg" /></a> </div> </div> </div> </div> </div> </section> </div> </div> <footer> <div class="footer_inner clearfix"> <div class="footer_top_holder"> <div class="footer_top"> <div class="container"> <div class="container_inner"> <div class="four_columns clearfix"> <div class="col"> <h2 class="rounded"><a href="https://www.alnylam.com/about-alnylam/">Our Company</a></h2> <div class="textwidget"> <a href="https://www.alnylam.com/about-alnylam/">Our Company</a> <a href="https://www.alnylam.com/our-science/the-science-of-rnai">Our Science</a> <a href="https://www.alnylam.com/our-products">Our Products</a> <a href="https://news.alnylam.com/">Our News</a> </div> </div> <div class="col"> <h2 class="rounded"><a href="http://investors.alnylam.com/">Investors</a></h2> <div class="textwidget"> <a href="https://investors.alnylam.com/">Investors</a> <a href="https://www.alnylam.com/medical-professional-resources/">Medical Professionals</a> <a href="https://www.alnylam.com/patients/">Patients</a> <a href="https://www.alnylam.com/careers/">Job Seekers</a> </div> </div> <div class="col"> <h2 class="rounded"><a href="https://www.alnylam.com/alnylam-rnai-pipeline/clinical-trials/">Clinical Trials</a></h2> <div class="textwidget"> <a href="https://www.alnylam.com/alnylam-rnai-pipeline/clinical-trials/">Clinical Trials</a> <a href="https://www.alnylam.com/about-alnylam/corporate-responsibility/">Corporate Responsibility</a> <a href="https://www.alnylam.com/about-alnylam/diversity-inclusion/">Diversity, Equity & Inclusion</a> <a href="https://investors.alnylam.com/press-releases">Press Releases</a> <a href="https://capella.alnylam.com/our-science/capella-rnai-innovation/">Capella</a> <a href="https://www.rnaiscience.com/">Medical Resources (RNAi Science)</a> <a href="https://www.alnylam.com/contact-us/">Contact Us</a> <a href="https://www.alnylam.com/signup-for-updates">Sign Up For Updates</a> </div> </div> <div class="col"> <h2 class="rounded"><a href="https://alnylampolicies.com/privacy">Privacy Policy</a></h2> <div class="textwidget"> <a href="https://alnylampolicies.com/privacy">Privacy Policy</a> <a href="https://www.alnylam.com/media-kit/">Media Kit</a> <a href="https://alnylampolicies.com/legal/">Legal Notice</a> <a href="https://www.alnylam.com/sitemap/">Site Map</a> <a href="https://www.alnylam.com/signup-for-updates">Sign Up For Updates</a> </div> </div> </div> </div> </div> </div> </div> <div class="footer_bottom_holder"> <div class="footer_bottom"> <div class="textwidget"> <div class="container_inner"> <div class="left-footer-bottom" style="text-align:right;"> <span class="copyright">Copyright © <span class="timer"> </span> Alnylam Pharmaceuticals, Inc. — All Rights Reserved</span> <span class="social_wrapper"> <span class="social_header_text">Follow Us:</span> <span class="q_social_icon_holder normal_social"> <a itemprop="url" href="https://www.youtube.com/channel/UCUZReY0GSAJ1w-MULQb9_Rw" target="_blank"> <i class="qode_icon_font_awesome fa fa-youtube-play fa-lg simple_social" style="font-size: 17px;"></i> </a> </span> <span class="q_social_icon_holder normal_social"> <a itemprop="url" href="https://www.facebook.com/AlnylamPharma/" target="_blank"> <i class="qode_icon_font_awesome fab fa-facebook fa-lg simple_social" style="font-size: 17px;"></i> </a> </span> <span class="q_social_icon_holder normal_social"> <a itemprop="url" href="https://twitter.com/alnylam" target="_blank"> <i class="qode_icon_font_awesome fa-brands fa-x-twitter fa-lg simple_social" style="font-size: 17px;"></i> </a> </span> <span class="q_social_icon_holder normal_social"> <a itemprop="url" href="https://www.linkedin.com/company/alnylam-pharmaceuticals/" target="_blank"> <i class="qode_icon_font_awesome fa fa-linkedin fa-lg simple_social" style="font-size: 17px;"></i> </a> </span> <span class="q_social_icon_holder normal_social"> <a itemprop="url" href="https://www.instagram.com/alnylampharma/" target="_blank"> <i class="qode_icon_font_awesome fa fa-instagram fa-lg simple_social" style="font-size: 17px;"></i> </a> </span> <span class="q_social_icon_holder normal_social"> <a itemprop="url" href="https://www.alnylam.com/signup-for-updates" target="_blank"> <i class="qode_icon_font_awesome fa fa-envelope fa-lg simple_social" style="font-size: 17px;"></i> </a> </span> </span> </div> <div class="clearfix_footer"></div> </div> </div> </div> </div> </div> </footer> </div> </div> <div id="external_popup" class="lity-hide"> <div class="inner"> <h3>You are now leaving Alnylam.com</h3> <p>The following content may not be associated with Alnylam Pharmaceuticals.</p> <p>Links to all outside sites are provided as a reference for our visitors.</p> <p>Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.</p> <a target="_blank" href="#" class="confirm internal">Proceed to Site</a> <button class="close" aria-label="Close (Press escape to close)" data-lity-close=""> </button> </div> </div>  <script type="application/json" data-drupal-selector="drupal-settings-json">{"path":{"baseUrl":"\/","scriptPath":null,"pathPrefix":"","currentPath":"node\/166","currentPathIsAdmin":false,"isFront":false,"currentLanguage":"en"},"pluralDelimiter":"\u0003","suppressDeprecationErrors":true,"user":{"uid":0,"permissionsHash":"fb44ca0584ad3663b3e9ecf81c7f212dc0759e7ab27fe68faaa0da8509fb76f2"}}</script> <script src="/core/assets/vendor/jquery/jquery.min.js?v=3.6.0"></script> <script src="/core/misc/polyfills/element.matches.js?v=9.4.8"></script> <script src="/core/misc/polyfills/object.assign.js?v=9.4.8"></script> <script src="/core/assets/vendor/once/once.min.js?v=1.0.1"></script> <script src="/core/assets/vendor/jquery-once/jquery.once.min.js?v=2.2.3"></script> <script src="/core/misc/drupalSettingsLoader.js?v=9.4.8"></script> <script src="/core/misc/drupal.js?v=9.4.8"></script> <script src="/core/misc/drupal.init.js?v=9.4.8"></script> <script src="/core/misc/jquery.once.bc.js?v=9.4.8"></script> <script src="/themes/custom/alnylam/js/jquery.migrate.js?v=9.4.8"></script> <script src="/themes/custom/alnylam/js/slick.min.js?v=9.4.8"></script> <script src="/themes/custom/alnylam/js/lity.min.js?v=9.4.8"></script> <script src="/themes/custom/alnylam/js/common.js?v=9.4.8"></script> <script src="/themes/custom/alnylam/js/theme.js?v=9.4.8"></script> <script src="/modules/custom/alnylam_search/js/alnylam_search.js?v=1"></script> <script src="https://gto-cookie-oven.s3.us-east-2.amazonaws.com/widget.js" type="text/javascript"></script> <script type="text/javascript">window.NREUM||(NREUM={});NREUM.info={"beacon":"bam.nr-data.net","licenseKey":"c3ddcf012e","applicationID":"347217331","transactionName":"ZwcDMktUDxFYB0dfC15NIAVNXA4MFiBBQxRRDj0IVlEEPnoLXUIWXw4NA0tpLw1dAWVfAUchDghNRw4OVQFBG1pGCwQR","queueTime":0,"applicationTime":197,"atts":"S0AARANOHB8=","errorBeacon":"bam.nr-data.net","agent":""}</script></body> </html>

CINXE.COM

2023 Year in Review: CEO Yvonne Greenstreet Reflects on a Year of Substantial Growth and Progress | Alnylam® Newsroom